PFG Investments’s Verona Pharma VRNA Stock Holding History

PFG Investments’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,600	Closed	-$1.66M	–	1228
2025 Q3	$1.66M	Sell	15,600 -8,100	-34%	-$846K	0.09%	219
2025 Q2	$2.24M	Sell	23,700 -2,300	-9%	-$170K	0.13%	148
2025 Q1	$1.65M	Sell	26,000 -3,700	-12%	-$221K	0.11%	193
2024 Q4	$1.38M	Sell	29,700 -7,100	-19%	-$267K	0.09%	222
2024 Q3	$1.06M	Sell	36,800 -7,800	-17%	-$192K	0.07%	289
2024 Q2	$645K	Buy	44,600 +18,000	+68%	+$263K	0.05%	365
2024 Q1	$428K	Buy	26,600 +8,800	+49%	+$152K	0.03%	593
2023 Q4	$354K	Buy	+17,800	New	+$263K	0.07%	316

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

PFG Investments's VRNA Position: Q4 2025 in Review

PFG Investments sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 15,600 shares — an estimated $1.66M sold.

PFG Investments first reported a position in VRNA in Q4 2023 and held it in 8 quarters. The position peaked at $2.24M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

PFG Investments reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
PFG Investments sold 15,600 Verona Pharma shares in Q4 2025, an estimated $1.66M.
PFG Investments first reported a position in Verona Pharma in Q4 2023 and held it in 8 quarters.
PFG Investments's Verona Pharma position peaked at $2.24M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on PFG Investments's 13F filing for Q4 2025, filed 26 Jan 2026.